Connect with us

Hi, what are you looking for?

Op-Ed

Curious about taking ‘drug holiday’ from ARV

An HIV-positive Filipino was told about “ARV drug holiday” (that is, taking a break from taking his ARV) and wants to know more about this. Dr. Jose Narciso Melchor Sescon provides needed information on this.

Dr. Jose Narciso Melchor Sescon – president of the AIDS Society of the Philippines and current Chief of Clinics of Sta. Ana Hospital – answers all your HIV-related inquiries. For all your questions, email josescon1@gmail.com or info@outragemag.com.

Dear Doc,

My friends from Africa mentioned to me that there are PLHIVs there who go on drug holidays to allow the body to recuperate from the stress caused by the meds. Can I also practice this?

Mr. Holiday

The rule of thumb to keep in mind is that drug therapy regimen is customized to the needs of the patient. Never compare your ARV treatment plan with the other clients since, for all you know, there are other factors that your HIV specialist considered when he/she gave you your specific drug combinations.  Also, you may not have been informed, they may be part of a “new” research protocol or design on ARV treatment (which may not work for you). So never mess up with the instructions given to you by your HIV specialists.

Drug holidays, or otherwise known as “structured treatment interruptions” (also known as STI, though NOT to refer to sexually transmitted infections), is an evolving trend in other developing/developed countries where there have been ARV treatment practice for more than three decades.

The fact remains that antiretroviral (ARV) therapy improves the health of persons with HIV by suppressing the virus and thus slowing the progression of the disease to AIDS condition.

On the other hand, the drugs have side effects, are expensive, and many people find it difficult to take them for long periods without any breaks.

Some scientists came to think and proposed that it might in fact be a good thing to have “breaks” from antiretroviral treatment in order to stimulate the body’s immune response to HIV. When HIV is suppressed to very low levels in the blood for long periods (as occurs with antiretroviral therapy), a person might lose his/her natural immune response to the virus. Notably, the immune system is a very important body mechanism in controlling the virus, along with antiretroviral treatment.

Advertisement. Scroll to continue reading.

If treatment is stopped, the virus quickly multiplies and levels in the blood rise. This could serve to “switch on” and strengthen the immune response, in a process that has been called “auto vaccination”.

A small number of scientific studies with people on antiretroviral treatment set out to study what would happen if there were controlled, short treatment breaks, called structured treatment interruptions or “drug holidays”. These studies have shown that there is measurable, increased recognition of the HIV by the immune system following treatment breaks. However, these effects on the immune system are similar to what is found in people before treatment, and do not seem to have long-term benefits in people with established HIV infection.

(There may be more benefit in people who started antiretroviral treatment very soon after they were infected with HIV.)

Another concern is that there is evidence that drug resistance is more likely to occur following structured treatment interruptions, just as it is more likely to occur when people interrupt their treatment for other reasons.

Because at this stage there is no clear answer as to whether structured treatment interruptions is a good thing, and also because of the uncertainty about how often and how long interruptions should be, structured treatment interruptions is not advised for any person on antiretroviral treatment except as part of a properly controlled and monitored scientific study.

Many scientists now believe that it is probably safer to use other ways to stimulate an immune response to HIV in patients on treatment. Such methods could include cytokines (immune messenger molecules) or HIV vaccines, and NOT structured treatment interruptions.

So it is NOT SMART to go drug holidays on your own without the HIV specialists’ recommendations. Otherwise, you are part of a randomized control trial study on drug resistances/and drug holidays efficacy.

Fondly called Jojo, Jose Narciso Melchor Sescon is a medical doctor with specialization in obstetrics and gynecology. Spending much of his time in public health services with focus on HIV and AIDS, STI, and sexual and reproductive health, Jojo wears multiple hats, blending public health advocacy and clinical-cum-administrative work. For 12 years, he served as the Executive Director of Remedios AIDS Foundation, the pioneering AIDS service organization in the Philippines. Then in 2008, he assumed the presidency of the AIDS Society of the Philippines, which he still heads now. Jojo is also the current Chief of Clinics of Sta. Ana Hospital, and has held regional and local consultancy works for development agencies. Jojo is a self-confessed lacto-vegetarian, a raja yoga meditation practitioner, and a health/wellness buff. He also loves to share his thoughts and reflections based on learned skills/competencies and experiences. This soft-spoken soul loves taking on new initiatives/roles, and loves to talk with people about spirituality and good health.

Advertisement
Advertisement

Like Us On Facebook

YOU MAY ALSO LIKE

POZ

Climate change-related extreme weather events, such as drought and flooding, were associated with poorer HIV prevention outcomes, including reduced HIV testing. Extreme weather events...

Op-Ed

Meet 33-year-old Macu, who actively seeks for ways for him to be infected with HIV. Nowadays, people with HIV may no longer infect others...

NEWSMAKERS

Ladlad, the pioneering LGBTQIA political party in the Philippines, partnered with Positive Action Foundation Philippines Inc. (PAFPI), a non-profit organization catering to the HIV...

POZ

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living...

Advertisement